Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents...
-
date post
19-Dec-2015 -
Category
Documents
-
view
227 -
download
0
Transcript of Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents...
![Page 1: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/1.jpg)
Medicine Access: Claims & Data
Sanjay Basu
![Page 2: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/2.jpg)
The Framework for Access
The pipeline fallacy Patents and pricing
![Page 3: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/3.jpg)
TRIPs measures
TRIPs & the WTO Parallel importation Compulsory licensing
![Page 4: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/4.jpg)
What generics help do…
![Page 5: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/5.jpg)
Are generics ‘illegitimate’?
The claim: Generic competition will undermine the pharma industry and future R&D
TRIPs-plus and Special 301
![Page 6: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/6.jpg)
R&D spending?
![Page 7: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/7.jpg)
Who pays?
![Page 8: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/8.jpg)
A lesson from AIDS drugs
![Page 9: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/9.jpg)
![Page 10: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/10.jpg)
The Doha Declaration
– “The TRIPS Agreement does not and should not prevent Members from taking measures to protect public health”
– The WTO will operate to facilitate “access to medicines for all”
– “We recognize that WTO members with insufficient or no manufacturing capacities in the pharmaceutical sector could face difficulties in making effective use of compulsory licensing under the TRIPS Agreement.”
![Page 11: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/11.jpg)
Doha derailed...
USTR (originally with EU and Japanese support) broke initial deadline for negotiations
This month: 17-page decision ...but existing flexibilities apply New infrastructure being built in southern
Africa by Brazil
![Page 12: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/12.jpg)
Things to watch out for...
“The documents show that the trade association, the Pharmaceutical Research and Manufacturers of America, known as PhRMA, will spend at least $150 million in the coming year.”
“The drug trade group plans to spend $1 million for an "intellectual echo chamber of economists”--a standing network of economists and thought leaders to speak against federal price control regulations through articles and testimony, and to serve as a rapid response team.“
“At least $2 million, and perhaps $2.5 million, in payments to research and policy organizations, "to build intellectual capital and generate a higher volume of messages from credible sources" sympathetic to the industry.”
“In addition, the budget sets aside $17.5 million to fight price controls and protect patent rights in foreign countries and in trade negotiations.”
“$9.4 million for public relations, including "$1 million for inside-the-Beltway advertising, $555,000 for placement of op-eds and articles by third parties," $600,000 for polling, $1.3 million for local publicity in 15 states and $680,000 for media relations consultants.”
![Page 13: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/13.jpg)
Things to watch out for...
Attaran, Gillespie-White and “off-patent essential medicines”
Roger Bate and “Africa Fighting Malaria” DiMasi’s “$800 million” R&D figure “Data exclusivity”
![Page 14: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/14.jpg)
The new USTR proposals:
New “AIDS Czar” Chile – CAFTA – FTAA – PPP Singapore – Indonesia/Thailand – ASEAN SACU Projected December completion date
![Page 15: Medicine Access: Claims & Data Sanjay Basu. The Framework for Access The pipeline fallacy Patents and pricing.](https://reader030.fdocuments.in/reader030/viewer/2022033107/56649d3b5503460f94a15aa3/html5/thumbnails/15.jpg)
More information…
www.essentialmedicines.org www.geocities.com/medicinepolicy www.accessmed-msf.org ****Dying for Growth: Global Inequality and the
Health of the Poor (Kim et al., 2000) ****Pathologies of Power: Health, Human Rights and
the New War on the Poor (Farmer, 2003) Siamese Tragedies: Development & Disintegration in
Modern Thailand (Bello et al., 1998) Global Intellectual Property Rights: Knowledge,
Access and Development (Drahos & Mayne, 2002)